Evidence map›Paper›PMID 41073910›Full record

ArticleBMC cardiovascular disorders2025

A novel risk model combining clinical and intravascular ultrasound-based calcific features to predict adverse outcomes in patients with severe coronary artery calcification undergoing percutaneous coronary intervention: the mACEF- Ca model.

Xi Wu, Mingxing Wu, Haobo Huang, Zhe Liu, He Huang, Lei Wang

Abstract read
In one paragraph

Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xi WuDepartment of Cardiology, Xiangtan Central Hospital (the affiliated hospital of Hunan University), Xiangtan, 411100, Hunan, People's Republic of China.
Mingxing WuDepartment of Cardiology, Xiangtan Central Hospital (the affiliated hospital of Hunan University), Xiangtan, 411100, Hunan, People's Republic of China.
Haobo HuangDepartment of Cardiology, Xiangtan Central Hospital (the affiliated hospital of Hunan University), Xiangtan, 411100, Hunan, People's Republic of China.
Zhe LiuDepartment of Cardiology, Xiangtan Central Hospital (the affiliated hospital of Hunan University), Xiangtan, 411100, Hunan, People's Republic of China.
He HuangDepartment of Cardiology, Xiangtan Central Hospital (the affiliated hospital of Hunan University), Xiangtan, 411100, Hunan, People's Republic of China.
Lei WangDepartment of Cardiology, Xiangtan Central Hospital (the affiliated hospital of Hunan University), Xiangtan, 411100, Hunan, People's Republic of China. heartwl@126.com.

Funding

National Innovation Center for High Performance Medical Devices NMED2025KF-02-011
6 · The paper itself

Abstract

backgroundSevere coronary artery calcification (CAC) significantly complicates percutaneous coronary intervention (PCI), leading to increased procedural challenges and adverse outcomes. Existing clinical risk models such as the age, creatinine and ejection fraction (ACEF) score often lack lesion-specific anatomical data, limiting their predictive performance in high-risk cohorts.

methodsThis retrospective study enrolled patients with intravascular ultrasound (IVUS)-confirmed severe CAC who underwent non-emergent PCI with drug-eluting stent implantation. Independent predictors of major adverse cardiovascular events (MACE) over a median 2-year follow-up were identified using multivariate Cox regression. A novel modified ACEF score (mACEF) incorporating calcific features (mACEF-Ca) was constructed based on the original mACEF, presence of calcified nodule (CN), and a maximum calcium arc of 360°.

resultsOf the 785 included patients, 121 (15.4%) experienced MACE during the 2-year follow-up. Presence of a 360° calcium arc and CN were identified as independent predictors of MACE (HR = 1.63 and 2.61, respectively; both P < 0.001). The simplified mACEF-Ca formula was: mACEF + 1 (if maximum calcium arc = 360°) + 1 (if CN present). This model demonstrated superior discrimination (AUC = 0.778) compared to traditional ACEF-based models (all P < 0.05 by DeLong test). Kaplan–Meier analysis confirmed significantly poorer event-free survival in patients with higher mACEF-Ca scores (log-rank P < 0.001).

conclusionThe mACEF-Ca score, combining clinical and IVUS-derived calcification parameters, enhances risk stratification in patients with severe CAC undergoing PCI. It offers a practical and effective tool for identifying high-risk individuals, guiding procedural planning, and informing post-procedural management strategies.

Indexed as

Coronary Artery DiseaseDecision Support TechniquesPercutaneous Coronary InterventionUltrasonography, InterventionalVascular CalcificationAgedDrug-Eluting StentsFemaleHumansMaleMiddle AgedPredictive Value of TestsRetrospective StudiesRisk AssessmentRisk FactorsSeverity of Illness IndexACEF scoreCalcified noduleCoronary artery calcificationIntravascular ultrasoundPercutaneous coronary intervention

Identifiers

PMID41073910
PMCPMC12512807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.